A review about the impact of multiple sclerosis on health-related quality of life

Disability and Rehabilitation

Volumn 25, Issue 22, 2003, Pages 1291-1303

  Benito León, Julián ^a,e   Morales, José Manuel ^b   Rivera Navarro, Jesús ^c   Mitchell, Alex J ^d  

^a HOSPITAL DE MÓSTOLES   (Spain)

^b Ministry of Social Affairs   (Spain)

^c UNIVERSIDAD VERACRUZANA   (Mexico)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON BETA SERINE; METHYLPREDNISOLONE; ALPHA2A INTERFERON; BACLOFEN; BETA INTERFERON; BETA1A INTERFERON;

ADJUSTMENT; CHRONIC DISEASE; CLINICAL PRACTICE; DISABILITY; EMOTION; HEALTH STATUS; HUMAN; LANGUAGE; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; SOCIAL ASPECT; WELLBEING; CLINICAL TRIAL; CORRELATION ANALYSIS; EMOTIONAL DISORDER; MEDICAL ASSESSMENT; MEDICAL RESEARCH; NEUROPSYCHIATRY; OCCUPATION; OUTCOMES RESEARCH; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; POPULATION RESEARCH; SIDE EFFECT; SOCIAL STATUS; TAI CHI; VALIDATION PROCESS;

COGNITION DISORDERS; DEPRESSION; DISABILITY EVALUATION; DISEASE PROGRESSION; FATIGUE; HUMANS; MULTIPLE SCLEROSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SICKNESS IMPACT PROFILE;

EID: 0345169866     PISSN: 09638288     EISSN: None     Source Type: Journal    
DOI: 10.1080/09638280310001608591     Document Type: Review

References (129)

1. Stenager E, Stenager EN, Knudsen L, Jensen K. Multiple sclerosis: the impact on family and social life. Acta Psychiatrica Belgica 1994; 94: 165-174.
2. Rivera-Navarro J, Morales JM, Benito-León J. Informal caregiving in multiple sclerosis patients: Data from the demyelinating diseases study group from Madrid. Disability and Rehabilitation; 25(18): 1057-1064
3. Lynch SG, Kroencke DC, Denney DR. The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Multiple Sclerosis 2001; 7: 411-416.
4. Patrick DL, Bergner M. Measurement of health status in the 1990s. Annual Review of Public Health 1990; 11: 165-183.
5. Egli H. What constitutes quality of life? Methodological considerations and suggestions for clinical practice. Scandinavian Journal of Gastroenterology 1987; 22(suppl.): S87-S9.
6. Carr AJ, Gibson B, Robinson PG. Measuring quality of life: Is quality of life determined by expectations or experience? BMJ 2001; 322: 1240-1243.
7. Miller DM. Health-related quality of life. Multiple Sclerosis 2002; 8: 269-270.
8. Kurtzke JF. On the Evaluation of Disability in Multiple Sclerosis. Neurology 1961; 11: 686-694.
9. Rudick RA, Miller D, Clough JD, Gragg LA, Farmer RG. Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Archives of Neurology 1992; 49: 1237-1242.
10. Benito-León J, Martínez-Martín P. Calidad de vida relacionada con la salud en la esclerosis múltiple. Neurología 2003; 18: 210-217.
11. Dickersin K, Scherer R, Lefebvre C. Systematic Reviews-Identifying Relevant Studies For Systematic Reviews. British Medical Journal 1994; 309: 1286-1291.
12. Ratsep T, Kallasmaa T, Pulver A, Gross-Paju K. Personality as a predictor of coping efforts in patients with multiple sclerosis. Multiple Sclerosis 2000; 6: 397-402.
13. McCabe MP, McKern S. Quality of life and multiple sclerosis: Comparison between people with multiple sclerosis and people from the general population. Journal of Clinical Psychology Med Settings 2002; 9: 287-295.
14. Hermann BP, Vickrey B, Hays RD, Cramer J, Devinsky O, Meador K, Perrine K, Myers LW, Ellison GW. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Research 1996; 25(2): 113-118.
15. Cella DF, Dineen K, Arnason B, Reder A, Webster KA, Karabatsos G, Chang C, Lloyd S, Steward J, Stefoski D. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996; 47: 129-139.
16. Hernández MA. Esclerosis múltiple y calidad de vida. Revista de Neurologia 1996; 24: 1221-1223.
17. Rothwell PM. Quality of life in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1998; 65: 433.
18. Hernández MA. Tratamiento de la esclerosis múltiple y calidad de vida. Revista de Neurologia 2000; 30: 1242-1245.
19. Vernay D, Gerbaud L, Clavelou P. Qualité de vie et sclérose en plaques. Revue Neurologique (Paris) 2001; 157: 1139-1142.
20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
21. Hobart J, Freeman JA, Thompson AJ. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000; 123: 1027-1040.
22. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122: 871-882.
23. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. British Medical Journal 1997; 314: 1580-1583.
24. Cheng EM, Hays RD, Myers LW, Ellison GW, Beckstrand M, Vickrey BG. Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scores. Multiple Sclerosis 2001; 7: 405-410.
25. Schwartz L, Kraft GH. The role of spouse responses to disability and family environment in multiple sclerosis. American Journal of Physical Medicine and Rehabilitation 1999; 78: 525-532.
26. Rees J, O'Boyle C, MacDonagh R. Quality of life: impact of chronic illness on the partner. Journal of the Royal Society of Medicine 2001; 94: 563-566.
27. Thompson AJ. Progress in neurorehabilitation in multiple sclerosis. Current Opinion in Neurology 2002; 15: 267-270.
28. Nortvedt MW, Riise T. The use of quality of life measures in multiple sclerosis research. Multiple Sclerosis 2003; 9: 63-72.
29. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology 1999; 53: 1098-1103.
30. Pfennings L, Cohen L, Ader H, Polman C, Lankhorst G, Smits R, van der Ploeg H. Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. Journal of Neurology 1999; 246: 587-591.
31. Lintern TC, Beaumont JG, Kenealy PM, Murrell RC. Quality of life (QoL) in severely disabled multiple sclerosis patients: comparison of three QoL measures using multidimensional scaling. Quality of Life Research 2001; 10: 371-378.
32. Bethoux F, Miller DM, Kinkel RP. Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life. Mult Scler 2001; 7: 137-142.
33. Murphy N, Confavreux C, Haas J, et al. Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. Cost of Multiple Sclerosis Study Group. Journal of Neurology, Neurosurgery and Psychiatry 1998; 65: 460-466.
34. Freeman J, Langdon DW, Hobart JC, Thompson AJ. Health-related quality of life in people with multiple sclerosis undergoing inpatient rehabilitation. Journal of Neurol Rehabil 1996; 10: 185-194.
35. Schwartz CE, Coulthard-Morris L, Cole B, Vollmer T. The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWIST analysis. Archives of Neurology 1997; 54: 1475-1480.
36. Nortvedt MW, Riise T, Myhr KM, Nyland HI, Hanestad BR. Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a. Multiple Sclerosis 1999; 5: 317-322.
37. Rice GP, Oger J, Duquette P, et al. Treatment with interferon beta-1b improves quality of life in multiple sclerosis. Canadian Journal of Neurological Sciences 1999; 26: 276-282.
38. Arnoldus JH, Killestein J, Pfennings LE, Jelles B, Uitdehaag BM, Polman CH. Quality of life during the first 6 months of interferon-beta treatment in patients with MS. Multiple Sclerosis 2000; 6: 338-342.
39. Freeman JA, Thompson AJ, Fitzpatrick R, Hutchinson M, Miltenburger C, Beckmann K, Dahlke F, Kappos L, Polman C, Pozzilli C. Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life. Neurology 2001; 57: 1870-1875.
40. Vermersch P, de Seze J, Delisse B, Lemaire S, Stojkovic T. Quality of life in multiple sclerosis: influence of interferon-beta1a (Avonex) treatment. Multiple Sclerosis 2002; 8: 377-381.
41. Jenkinson C, Fitspatrick R, Argyle M. The Nottingham Health Profile: An analysis of its sensitivity in differentiating illness groups. Soc Sci Med 1988; 27: 1411-1414.
42. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Medical Care 1981; 19: 787-805.
43. Schwartz L, Kraft GH. The role of spouse responses to disability and family environment in multiple sclerosis. American Journal of Physical Medicine and Rehabilitation 1999; 78: 525-532.
44. Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992; 30: 473-83.
45. Brooks R. EuroQoL: the current state of play. Health Policy 1996; 37: 53-72.
46. Murrell RC, Kenealy PM. Assessing quality of life in persons with severe neurological disability associated with multiple sclerosis: the psychometric evaluation of two quality of life measures. British Journal of Health Psychology 1999; 4: 349-362.
47. Sharrack B, Hughes RA, Soudain S, Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 1999; 122: 141-159
48. Nortvedt MW, Riise T, Myhr KM, Landtblom AM, Bakke A, Nyland HI. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis 2001; 7: 231-235.
49. Somerset M, Campbell R, Sharp D, Peters TJ. What do people with MS want and expect from health-care services? Health Expectations 2001; 4: 29-37.
50. Brunet DG, Hopman WM, Singer MA, Edgar CM, MacKenzie TA. Measurement of health-related quality of life in multiple sclerosis patients. Canadian Journal of Neurological Sciences 1996; 23: 99-103.
51. Freeman JA, Hobart JC, Langdon DW, Thompson AJ. Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 2000; 68: 150-156.
52. Pfennings L, Cohen L, Miller D, Gerbaud L, Vleugels L, Freeman J, Vernay D, Biolay S, Ketelaer P, Thompson A, Polman C, van der Ploeg H. Using the short form-36 with multiple sclerosis patients in five countries: a cross-cultural comparison. Psychological Reports 1999; 85: 19-31.
53. Pozzilli C, Brunetti M, Amicosante AM, Gasperini C, Ristori G, Palmisano L, Battaglia M. Home based management in multiple sclerosis: results of a randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry 2002; 73: 250-255.
54. Hobart J, Freeman J, Lamping D, Fitzpatrick R, Thompson A. The SF-36 in multiple sclerosis: why basic assumptions must be tested. Journal of Neurology, Neurosurgery and Psychiatry 2001; 71: 363-370.
55. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Medical Care 2000; 38: 1022-1028.
56. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Quality of Life Research 1995; 4: 187-206.
57. Vickrey BG, Hays RD, Genovese BJ, Myers LW, Ellison GW. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. Journal of Clinical Epidemiology 1997; 50: 557-569.
58. Solari A, Radice D. Health status of people with multiple sclerosis: a community mail survey. Neurological Sciences 2001; 22: 307-315.
59. Schwartz CE, Brotman S, La Rocca N, Lee H. Patient perception of quality of care provided by specialists and generalists. Multiple Sclerosis 1998; 4: 426-432.
60. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Economics 1993; 2: 217-227.
61. Freeman JA, Hobart JC, Thompson AJ. Does adding MS-specific items to a generic measure (the SF-36) improve measurement? Neurology 2001; 57: 68-74.
62. Lankhorst GJ, Jelles F, Smits RC, Polman CH, Kuik DJ, Pfennings LE, Cohen L, van der Ploeg HM, Ketelaer P, Vleugels L. Quality of life in multiple sclerosis: the disability and impact profile (DIP). Journal of Neurology 1996; 243: 469-474.
63. Pfennings LE, van der Ploeg HM, Cohen L, Polman CH. A comparison of responsiveness indices in multiple sclerosis patients. Quality of Life Research 1999; 8: 481-489.
64. Jonsson A, Dock J, Ravnborg MH. Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis. Acta Neurologica Scandinavica 1996; 93: 229-35.
65. Cohen L, Pouwer F, Pfennings LE, Lankhorst GJ, van der Ploeg HM, Polman CH, Ader HJ, Jonnson A, Vleugels L. Factor structure of the Disability and Impact Profile in patients with multiple sclerosis. Quality of Life Research 1999; 8: 141-150.
66. Pfennings L, Cohen L, van der Ploeg H, Polman C, Lankhorst G. Reliability of two measures of health-related quality of life in patients with multiple sclerosis. Perceptual and Motor Skills 1998; 87: 111-114.
67. Chang CH, Cella DF, Fernández O, et al. Quality of life in multiple sclerosis patients in Spain. Multiple Sclerosis 2002; 8: 527-531.
68. Modrego PJ, Pina MA, Simon A, Azuara MC. The interrelations between disability and quality of life in patients with multiple sclerosis in the area of Bajo Aragon, Spain: a geographically based survey. Neurorehabil Neural Repair 2001; 15: 69-73.
69. Rivera-Navarro J, Benito-León J, Morales JMG, grupo GEDMA. Hacia la búsqueda de dimensiones más especificas en la medición de la calidad de vida en la esclerosis múltiple. Revista de Neurologia 2001; 32: 705-714.
70. Benito-León J, Morales JM, River-Navarro J. Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. European Neurology 2002; 9: 497-502.
71. Nicholl CR, Lincoln NB, Francis VM, Stephan TF. Assessing quality of life in people with multiple sclerosis. Disability and Rehabilitation 2001; 23: 597-603.
72. Gold SM, Heesen C, Schulz H, et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Multiple Sclerosis 2001; 7: 119-130.
73. Ford HL, Gerry E, Tennant A, Whalley D, Haigh R, Johnson MH. Developing a disease-specific quality of life measure for people with multiple sclerosis. Clinical Rehabilitation 2001; 15: 247-258.
74. Ford HL, Gerry E, Johnson MH, Tennant A. Health status and quality of life of people with multiple sclerosis. Disability and Rehabilitation 2001; 23: 516-521.
75. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001; 124: 962-973.
76. Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Thompson AJ. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. Journal of Neurology, Neurosurgery and Psychiatry 2002; 73: 701-704.
77. Fischer JS, La Rocca NG, Miller DM, Ritvo PG, Andrews H, Paty D. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Multiple Sclerosis 1999; 5: 251-259.
78. Rotstein Z, Barak Y, Noy S, Achiron A. Quality of life in multiple sclerosis: development and validation of the 'RAYS' scale and comparison with the SF-36. International Journal of Quality Health Care 2000; 12: 511-517.
79. Pfennings LE, van der Ploeg HM, Cohen L, et al. A health-related quality of life questionnaire for multiple sclerosis patients. Acta Neurologica Scandinavica 1999; 100: 148-155.
80. Nelson E, Wasson J, Kirk J, Keller A, et al. Assessment of function in routine clinical practice: description of the COOP Chart method and preliminary findings. Journal of Chronic Dis 1987; 40(suppl. 1): 55S-69S.
81. Ferrans CE, Powers MJ. Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 1985; 8: 15-24.
82. Stuifbergen AK, Roberts GJ. Health promotion practices of women with multiple sclerosis. Archives of Physical Medicine and Rehabilitation 1997; 78(suppl. 5): S3-S9.
83. Stuifbergen AK. Cognitive impairment and perception of quality of life among individuals with multiple sclerosis. Rehabilitation Nurs Res 1995; 4: 11-18.
84. Stuifbergen AK. Health-promoting behaviors and quality of life among individuals with multiple sclerosis. Sch Inq Nurs Pract 1995; 9: 31-50.
85. Schwartz CE, Vollmer T, Lee H. Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Neurology 1999; 52: 63-70.
86. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Annals of Neurology 1996; 39: 432-41.
87. Jonsson A, Dock J, Ravnborg MH. Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis. Acta Neurologica Scandinavica 1996; 93: 229-235.
88. Di Fabio RP, Choi T, Soderberg J, Hansen CR. Health-related quality of life for patients with progressive multiple sclerosis: influence of rehabilitation. Physical Therapy 1997; 77: 1704-1716.
89. Sitzia J, Haddrell V, Rice-Oxley M. Evaluation of a nurse-led multidisciplinary neurological rehabilitation programme using the Nottingham Health Profile. Clinical Rehabilitation 1998; 12: 389-394.
90. Gianino JM, York MM, Paice JA, Shott S. Quality of life: effect of reduced spasticity from intrathecal baclofen. Journal of Neuroscience Nursing 1998; 30: 47-54.
91. Husted C, Pham L, Hekking A, Niederman R. Improving quality of life for people with chronic conditions: the example of t'ai chi and multiple sclerosis. Altern Ther Health Med 1999; 5: 70-74.
92. Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, la Mantia L, Farinotti M, Eoli M, Mendozzi L. Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 1999; 52: 57-62.
93. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? Neurology 1999; 52: 50-56.
94. Parkin D, Jacoby A, McNamee P, Miller P, Thomas S, Bates D. Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life. Journal of Neurology, Neurosurgery and Psychiatry 2000; 68: 144-149.
95. Mathiowetz V, Matuska KM, Murphy ME. Efficacy of an energy conservation course for persons with multiple sclerosis. Archives of Physical Medicine and Rehabilitation 2001; 82: 449-456.
96. Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF, Sandrock AW, Rudick RA, Simon JH, Simonian NA, Tsao EC, Whitaker JN. Benefit of interferon beta-1a on MSFC progression in secondary Progressive MS. Neurology 2002; 59: 679-687.
97. Patti F, Ciancio MR, Reggio E, Lopes R, Palermo F, Cacopardo M, Reggio A. The impact of outpatient rehabilitation on quality of life in multiple sclerosis. Journal of Neurology 2002; 249: 1027-1033.
98. Janardhan V, Bakshi R. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Archives of Neurology 2000; 57: 1485-91.
99. Miller DM, Rudick RA, Cutter G, Baier M, Fischer JS. Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. Archives of Neurology 2000; 57: 1319-1324.
100. de Andrés C, Guillem A. Una aproximación sobre la calidad de vida en pacientes con esclerosis multiple. Revista de Neurologia 2000; 30: 1229-1234.
101. Henriksson F, Fredrikson S, Masterman T, Jonsson B. Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. European Journal of Neurology 2001; 8: 27-35.
102. O'Connor P, Lee L, Ng PT, Narayana P, Wolinsky JS. Determinants of overall quality of life in secondary progressive MS: a longitudinal study. Neurology 2001; 57: 889-891.
103. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. Journal of Neurological Sciences 2002; 205: 51-58.
104. Koch LC, Rumrill Jr. PD, Roessler RT, Fitzgerald S. Illness and demographic correlates of quality of life among people with multiple sclerosis. Rehabil Psychol 2001; 46: 154-164.
105. Rudick RA, Cutter G, Baier M, Fisher E, Dougherty D, Weinstock-Guttman B, Mass MK, Miller D, Simonian NA. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Neurology 2001; 56: 1324-1330.
106. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life as a predictor for change in disability in MS. Neurology 2000; 55: 51-54.
107. The Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis: Part II: Quality of life. The Canadian Burden of Illness Study Group. Canadian Journal of Neurological Science 1998; 25: 31-38.
108. Kugler J, Kahrmann G, Gockel M, Pohlau D. Determinants for quality of life and emotional disorder in patients with multiple sclerosis. Psychosomatic Medicine 1999; 61: 111. (Abstract).
109. Barnwell AM, Kavanagh DJ. Prediction of psychological adjustment to multiple sclerosis. Social Science and Medicine 1997; 45: 411-418.
110. Aronson KJ. Quality of life among persons with multiple sclerosis and their caregivers. Neurology 1997; 48: 74-80.
111. Burnfield A, Burnfield P. Psychosocial aspects of multiple sclerosis. Physiotherapy 1982; 68: 149-150.
112. Bagert B, Camplair P, Bourdette D. Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management. CNS Drugs 2002; 16: 445-455.
113. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41: 692-696.
114. Cutajar R, Ferriani E, Scandellari C, Sabattini L, Trocino C, Marchello LP, Stecchi S. Cognitive function and quality of life in multiple sclerosis patients. Journal of Neurovirology 2000; 6(suppl.): S186-S190.
115. Kenealy PM, Beaumont GJ, Lintern T, Murrell R. Autobiographical memory, depression and quality of life in multiple sclerosis. Journal of Clinical Experimental Neuropsychology 2000; 22: 125-131
116. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. General Hospital Psychiatry 1987; 9: 426-434.
117. Provinciali L, Ceravolo MG, Bartolini M, Logullo F, Danni M. A multidimensional assessment of multiple sclerosis: relationships between disability domains. Acta Neurologica Scandinavica 1999; 100: 156-162.
118. Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbieri E, Baldini S, Salmaggi A, La Mantia L, Farinotti M, Caputo D, Mosconi P. Validation of Italian multiple sclerosis quality of life 54 questionnaire. Journal of Neurology, Neurosurgery and Psychiatry 1999; 67: 158-162.
119. Bakshi R, Shaikh ZA, Miletich RS, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Multiple Sclerosis 2000; 6: 181-185.
120. Wang JL, Reimer MA, Metz LM, Patten SB. Major depression and quality of life in individuals with multiple sclerosis. International Journal of Psychiatry in Medicine 2000; 30: 309-317.
121. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Multiple Sclerosis 2001; 7: 340-344.
122. Fruehwald S, Loeffler-Stastka H, Eher R, Saletu B, Baumhackl U. Depression and quality of life in multiple sclerosis. Acta Neurologica Scandinavica 2001; 104: 257-261.
123. Merkelbach S, Sittinger H, Koenig J. Is there a differential impact of fatigue and physical disability on quality of life in multiple sclerosis? Journal of Nervous and Mental Disease 2002; 190: 388-393.
124. Morales JM, Benito-León J, Rivera-Navarro J, Otero B. Relación de la fatiga con la calidad de vida relacionada con la salud y el estado emocional en la esclerosis múltiple. Neurología 2002; 17: 572. Abstract.
125. Schreurs KM, de Ridder DT, Bening JM. Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression. Journal of Psychosomatic Research 2002; 53: 775-781.
126. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in 34 patients with Parkinson's disease? Journal of Neurology, Neurosurgery and Psychiatry 2000; 69: 308-312.
127. Lou RS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003; 60: 122-123.
128. Kauhanen ML, Korpelainen JT, Hiltunen P, Nieminen P, Sotaniemi KA, Myllyla VV. Domains and determinants of quality of life after stroke caused by brain infarction. Archives of Physical Medicine and Rehabilitation 2000; 81: 1541-1546.
129. Knight RG, Devereux RC, Godfrey HPD. Psychosocial consequences of caring for a spouse with multiple sclerosis. Journal of Clinical and Experimental Neuropsychology 1997; 19: 7-19.